Atea-2026-JPM.pdf

1、1JP Morgan Healthcare ConferenceJanuary 15,20262DISCLAIMERSForward-Looking Statements This presentation contains“forward-looking statements”within the meaning of the Private Securities Litigation Reform Act of 1995.Forward-looking statements are neither historical facts nor assurances of future perf

2、ormance.Instead,they are based on our current beliefs,expectations and assumptions regarding the future of our business,future plans and strategies,our clinical results and other future conditions including without limitation the future of the HCV and HEV landscape and related commercial market oppo

3、rtunities.All statements other than statements of historical facts contained in this presentation are forward-looking statements,including statements by Atea Pharmaceuticals,Inc.(the“Company”)regarding future results of operations and financial position,including our anticipated cash runway;business

4、 strategy;current and prospective product candidates;anticipated milestone events;potential benefits of our product candidates and market opportunity;clinical trials,including,without limitation,anticipated initiation,enrollment,regulatory submission and data readout timelines;preclinical activities

5、;product approvals;manufacturing availability;degree of market acceptance of any products that may be approved;estimated total addressable market;research and development costs;prospective collaborations and strategic partnerships;and prospects and opportunities for investors.In some cases,you can i

6、dentify forward-looking statements by terms such as“may,”“will,”“should,”“expects,”“plans,”“anticipates,”“could,”“intends,”“targets,”“projects,”“contemplates,”“believes,”“estimates,”“predicts,”“potential”or“continue”or the negative of these terms or other similar expressions.The information in this